Home
About
Product
magNews
Career
Contact Us
中文
English
magNews
Corporate
Industry
Technology
Medical Updates
Corporate
MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held
2024-06-24
Corporate
NMPA grants approval to MoyoAssist® China's first full maglev extracorporeal VAD
2024-05-14
Corporate
magAssist Once Again Named in 2023 Future Healthcare VB100 List- China Innovative Medical Devices List
2023-05-09
Corporate
magAssist Forges University-Enterprise Cooperation with Domestic and International Universities to Empower Innovative Talents Cultivation Scheme
2023-01-12
Technology
2022 Critical Heart Disease Congress (CHDC·2022) | “BreathMo® - An Ultra-portable ECMO System” by Dr. Chia Hao Hsu from magAssist Inc.
2023-01-06
Technology
Professor Nianguo Dong of Wuhan Union Hospital Gives Speech Entitled “Clinical Experience with the MoyoAssist® Extracorporeal Ventricular Assist Device”
2023-01-06
Industry
Dr. Po-Lin Hsu from magAssist: Nothing is More Important than Saving Lives
2022-12-21
Corporate
magAssist Included in List of 2022 Potential Unicorn Companies in Jiangsu Province
2022-12-15
Corporate
Dr. Po-Lin Hsu Named on List of Forbes China - 100 Outstanding Overseas Returnees
2022-12-14
Corporate
Highlights|magAssist Invited to Join VBData’s Live Stream on The Future is Now a Reality! Percutaneous Ventricular Assist Devices Fast-tracked for Clinical Application
2022-12-12
Corporate
magAssist founder Dr. Po-Lin HSU, was selected as 2022 Most Influential Business Women——Future by FORTUNE China
2022-11-03
Corporate
MoyoAssist®, the winning project for Australian Good Design Awards and Designer Australia Awards 2022.
2022-09-30
Corporate
magAssist is on the list of Forbes Asia 100 to Watch 2022
2022-09-09
Medical Updates
The FIRST transseptal cannulation treatment via MoyoAssist Extra-VAD
2022-08-24
《
1
2
3
4
5
···
3/8
》
Tags:
Forum,
Conference,
Extra-VAD,
NMPA,
MoyoAssist,
Medical devices,
HRPCI,
Ventricular Assist Device,
NyokAssist,
FDA,
TOP